Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab (Vol 13, 973448, 2022)

被引：0
|
作者：
Frontiers Prod Off [1 ]
机构：
[1] Frontiers Media SA, Lausanne, Switzerland
来源：
FRONTIERS IN PHARMACOLOGY | 2022年 / 13卷
关键词：
anlotinib; non-small cell lung cancer (NSCLC); bevacizumab; efficacy; safety;
D O I：
10.3389/fphar.2022.1092147
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The safety and efficacy of paclitaxel and carboplatin with or without bevacizumab for treating patients with advanced nonsquamous non-small cell lung cancer with interstitial lung disease
    Shimizu, Ryoko
    Fujimoto, Daichi
    Kato, Ryoji
    Otoshi, Takehiro
    Kawamura, Takahisa
    Tamai, Koji
    Matsumoto, Takeshi
    Nagata, Kazuma
    Otsuka, Kyoko
    Nakagawa, Atsushi
    Otsuka, Kojiro
    Katakami, Nobuyuki
    Tomii, Keisuke
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (06) : 1159 - 1166
  • [42] Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer
    Zhou, Songwen
    Ren, Shengxiang
    Yan, Lianghua
    Zhang, Ling
    Tang, Liang
    Zhang, Jie
    Zhou, Caicun
    [J]. RESPIROLOGY, 2009, 14 (05) : 709 - 715
  • [43] Efficacy and safety of domestic and imported gefitinib in patients with advanced non-small cell lung cancer
    Cheng, Huawei
    Liu, Hongyue
    Du, Qiong
    Zhang, Hui
    Zhang, Xiaodan
    Wang, Yangkui
    Shao, Jingjing
    Yang, Feng
    Zhang, Bo
    Shi, Jing
    Liu, Yuguo
    Wu, Nan
    Xu, Silu
    Wei, Qing
    Sun, Yancai
    Zhai, Qing
    Yu, Bo
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 10 - 15
  • [44] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Meng-zhao
    [J]. 中华医学杂志(英文版), 2006, (01) : 63 - 68
  • [45] Efficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancer
    Cappuzzo, Federico
    Morabito, Alessandro
    Normanno, Nicola
    Bidoli, Paolo
    Del Conte, Alessandro
    Giannetta, Laura
    Montanino, Agnese
    Mazzoni, Francesca
    Buosi, Roberta
    Burgio, Marco Angelo
    Cerea, Giulio
    Chiari, Rita
    Cortinovis, Diego
    Finocchiaro, Giovanna
    Foltran, Luisa
    Migliorino, Maria Rita
    Tiseo, Marcello
    Ferrari, Silvia
    De Marinis, Filippo
    [J]. LUNG CANCER, 2016, 99 : 31 - 37
  • [46] EFFICACY AND SAFETY OF GEFITINIB AS MONOTHERAPY FOR CHINESE PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    WANG Mengzhao LI Longyun WANG Shulan ZHANG Xiaotong ZHONG Wei and ZHANG LiDepartment of Respiratory Diseases Peking Union Medical College Hospital Peking Union Medical College and Chinese Academy of Medical Sciences Beijing China
    [J]. ChineseMedicalJournal., 2006, (01) - 68
  • [47] Efficacy and safety of gefitinib as monotherapy for Chinese patients with advanced non-small cell lung cancer
    Wang, MZ
    Li, LY
    Wang, SL
    Zhang, XT
    Zhong, W
    Zhang, L
    [J]. CHINESE MEDICAL JOURNAL, 2006, 119 (01) : 63 - 68
  • [48] Efficacy and Safety of WBRT Combined with Endostar in Patients with Advanced Non-Small Cell Lung Cancer
    Dong, Xiaorong
    Zhang, Ruiguang
    Goa, Xican
    Liu, Pian
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S933 - S934
  • [49] EFFICACY AND SAFETY OF CHEMOTHERAPIES FOR ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS WITH INTERSTITIAL PNEUMONIA
    Sakai, M.
    Kubota, T.
    Kawase, S.
    Miyamoto, S.
    Yokoyama, A.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 82 - 82
  • [50] Efficacy and Safety of Anlotinib-Containing Regimens in Advanced Non-Small Cell Lung Cancer: A Real-World Study
    Sun, Lei
    Zhao, Qi
    Wang, Yanning
    Wang, Yongsheng
    Zheng, Ming
    Ding, Xuansheng
    Miao, Liyun
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 4165 - 4179
12345